GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical and Experimental Pharmacology and Physiology, Wiley, Vol. 45, No. 6 ( 2018-06), p. 499-506
    Abstract: Recently, meta‐analysis studies reported that hyperuricaemia is associated with higher incidence of type 2 diabetes mellitus (T2DM), however, there are limited data on the Asian population. The aim of this observational study is to estimate the long‐term impact of hyperuricaemia on the new‐onset T2DM and cardiovascular events. This study is based on a single‐centre, all‐comers, and large retrospective cohort. Subjects that visited from January 2004 to February 2014 were enrolled using the electronic database of Korea University Guro Hospital. A total of 10 505 patients without a history of T2DM were analyzed for uric acid, fasting glucose and haemoglobin (Hb) A1c level. Inclusion criteria included both Hb A1c 〈 5.7% and fasting glucose level 〈 100 mg/dL without T2DM. Hyperuricaemia was defined as a uric acid level ≥7.0 mg/dL in men, and ≥6.5 mg/dL in women. To adjust baseline confounders, a propensity score matching (PSM) analysis was performed. The impact of hyperuricaemia on the new‐onset T2DM and cardiovascular events were compared with the non‐hyperuricaemia during the 5‐year clinical follow‐up. After PSM, baseline characteristics of both groups were balanced. In a 5‐year follow‐up, the hyperuricaemia itself was a strong independent predictor of the incidence of new‐onset T2DM (HR, 1.78; 95% CI, 1.12 to 2.8). Hyperuricaemia was a strong independent predictor of new‐onset T2DM, which suggests a substantial implication for a correlation between uric acid concentration and insulin resistance (or insulin sensitivity). Also, hyperuricaemia is substantially implicated in cardiovascular risks and the further long‐term cardiovascular events in the crude population, but it is not an independent predictor of long‐term cardiovascular mortality in the matched population.
    Type of Medium: Online Resource
    ISSN: 0305-1870 , 1440-1681
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 2020033-X
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Clinical and Experimental Pharmacology and Physiology, Wiley, Vol. 47, No. 6 ( 2020-06), p. 947-954
    Abstract: Several studies suggest the higher vulnerability of individuals with lower low‐density lipoprotein cholesterol (LDL‐C) levels to diabetes mellitus. However, the discordance between high and low baseline LDL‐C levels shown by statin‐induced insulin resistance is not fully understood. This study aimed to explore the relationship between baseline LDL‐C levels and the risk of statin‐induced insulin resistance during statin therapy. In total, 2660 (451 with dyslipidemia and 2209 without dyslipidemia) consecutive patients were enrolled. Their baseline clinical data were adjusted using a propensity score matching analysis, using the logistic regression model. Insulin resistance index was based on the homeostatic model assessment‐insulin resistance (HOMA‐IR) and was monitored for a median of 2 years. Among the individuals who received statin therapy, those with and without dyslipidemia showed significantly decreased LDL‐C levels (all P   〈  .0001) and significantly increased fasting plasma insulin levels (Δ = +24.1%, P  = .0230; Δ = +30.1%, P   〈  .0001); however, their glycated haemoglobin A1c and fasting blood glucose levels did not change (all P   〉  .05). Although HOMA‐IR was positively associated with statin therapy in individuals with and without dyslipidemia, statistically significant difference during follow‐ups was observed only in individuals without dyslipidemia (Δ = +15.6%, P  = .1609; Δ = 24.0%; P  = .0001). Insulin resistance was higher in statin users without baseline dyslipidemia than in those with dyslipidemia. Thus, statin therapy could increase the risk of statin‐induced insulin resistance in individuals with normal baseline cholesterol levels.
    Type of Medium: Online Resource
    ISSN: 0305-1870 , 1440-1681
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2020033-X
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...